All news

All News
  • Legend
  • corporate
  • finance
  • sciences
  • Event

    15th International Congress on Targeted Anticancer Therapies (TAT 2017)

    Paris, France

    learn more
  • Press release

    Corporate Presentation February 2017

    learn more download
  • Press release

    Cellectis to Present at the LEERINK Partners 6th Annual Global Healthcare Conference on Thursday, February 16, 2017 at 1:30pm ET in New York

    February 7, 2017 – New York (N.Y.) – Cellectis (Alternext: ALCLS; Nasdaq: CLLS), a biopharmaceutical company focused on developing...

    learn more download
  • News

    Cellectis to Present at the LEERINK Partners 6th Annual Global Healthcare Conference on Thursday, February 16, 2017 at 1:30pm ET in New York

    read more download
  • Press release

    FDA Grants Cellectis IND Approval to Proceed with the Clinical Development of UCART123, the First Gene Edited Off-the-Shelf CAR T-Cell Product Candidate developed in the U.S.

    Cellectis’ UCART123 Product Candidate Targets AML and BPDCN ...

    learn more download

Pages